Loss of TREM2 rescues hyperactivation of microglia, but not lysosomal deficits and neurotoxicity in models of progranulin deficiency
Open Access
- 12 January 2022
- journal article
- research article
- Published by Springer Science and Business Media LLC in The EMBO Journal
- Vol. 41 (4), e109108
- https://doi.org/10.15252/embj.2021109108
Abstract
Haploinsufficiency of the progranulin (PGRN)-encoding gene (GRN) causes frontotemporal lobar degeneration (GRN-FTLD) and results in microglial hyperactivation, TREM2 activation, lysosomal dysfunction, and TDP-43 deposition. To understand the contribution of microglial hyperactivation to pathology, we used genetic and pharmacological approaches to suppress TREM2-dependent transition of microglia from a homeostatic to a disease-associated state. Trem2 deficiency in Grn KO mice reduced microglia hyperactivation. To explore antibody-mediated pharmacological modulation of TREM2-dependent microglial states, we identified antagonistic TREM2 antibodies. Treatment of macrophages from GRN-FTLD patients with these antibodies led to reduced TREM2 signaling due to its enhanced shedding. Furthermore, TREM2 antibody-treated PGRN-deficient microglia derived from human-induced pluripotent stem cells showed reduced microglial hyperactivation, TREM2 signaling, and phagocytic activity, but lysosomal dysfunction was not rescued. Similarly, lysosomal dysfunction, lipid dysregulation, and glucose hypometabolism of Grn KO mice were not rescued by TREM2 ablation. Synaptic loss and neurofilament light-chain (NfL) levels, a biomarker for neurodegeneration, were further elevated in the Grn/Trem2 KO cerebrospinal fluid (CSF). These findings suggest that TREM2-dependent microglia hyperactivation in models of GRN deficiency does not promote neurotoxicity, but rather neuroprotection.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (EXC 2145 SyNergy‐ID 390857198, BR4580/1‐1, HA1737/16‐1)
- Helmholtz-Gemeinschaft (ZT‐0027)
- BrightFocus Foundation (ADR AD2019604S)
- Alzheimer Forschung Initiative (19063p)
This publication has 97 references indexed in Scilit:
- TREM2 Variants in Alzheimer's DiseaseThe New England Journal of Medicine, 2013
- Variant ofTREM2Associated with the Risk of Alzheimer's DiseaseThe New England Journal of Medicine, 2013
- NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 miceNature, 2012
- Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injuryJCI Insight, 2012
- Strikingly Different Clinicopathological Phenotypes Determined by Progranulin-Mutation DosageAmerican Journal of Human Genetics, 2012
- Sortilin-Mediated Endocytosis Determines Levels of the Frontotemporal Dementia Protein, ProgranulinNeuron, 2010
- Alteration of behavioural phenotype in mice by targeted disruption of the progranulin geneBehavioural Brain Research, 2007
- Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17Nature, 2006
- Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21Nature, 2006
- Games Played by Rogue Proteins in Prion Disorders and Alzheimer's DiseaseScience, 2003